Vitruvian Partners’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Hold |
5,043,356
| – | – | 6.7% | 4 |
|
|
2025
Q1 | $13.8M | Hold |
5,043,356
| – | – | 13.13% | 3 |
|
|
2024
Q4 | $21M | Hold |
5,043,356
| – | – | 18.06% | 3 |
|
|
2024
Q3 | $19.6M | Hold |
5,043,356
| – | – | 7.62% | 4 |
|
|
2024
Q2 | $19.8M | Hold |
5,043,356
| – | – | 5.8% | 5 |
|
|
2024
Q1 | $21.1M | Hold |
5,043,356
| – | – | 6.7% | 5 |
|
|
2023
Q4 | $23.7M | Hold |
5,043,356
| – | – | 6.02% | 6 |
|
|
2023
Q3 | $15.7M | Hold |
5,043,356
| – | – | 4.46% | 6 |
|
|
2023
Q2 | $23.1M | Hold |
5,043,356
| – | – | 4.71% | 6 |
|
|
2023
Q1 | $25M | Hold |
5,043,356
| – | – | 5.33% | 5 |
|
|
2022
Q4 | $27.5M | Hold |
5,043,356
| – | – | 5.8% | 5 |
|
|
2022
Q3 | $32.8M | Hold |
5,043,356
| – | – | 5.85% | 5 |
|
|
2022
Q2 | $23.9M | Buy |
5,043,356
+657,686
| +15% | +$3.11M | 4.05% | 7 |
|
|
2022
Q1 | $30.7M | Buy |
4,385,670
+1,055,670
| +32% | +$7.38M | 3.25% | 7 |
|
|
2021
Q4 | $33.9M | Hold |
3,330,000
| – | – | 1.77% | 6 |
|
|
2021
Q3 | $40.7M | Buy |
+3,330,000
| New | +$40.7M | 1.7% | 5 |
|